target and capturing

Scil Proteins Enters Drug Discovery Collaboration with Ono for Affilin® Therapeutics

Halle, Germany, 15th May 2012 - Scil Proteins GmbH, a private biotech company specializing in the research, development and production of recombinant proteins, today announced that it has signed a collaboration agreement with Ono Pharmaceutical Co., Ltd. (Osaka, Japan), for the joint discovery and development of new Affilin® therapeutics to treat various diseases. Initially, Scil Proteins will identify and select Affilin® molecules directed against certain target(s) provided by Ono.